Multidisciplinary Lung Cancer Meetings: Improving the practice of radiation oncology and facing future challenges
- 12 January 2015
- journal article
- review article
- Published by Wiley in Respirology
- Vol. 20 (2) , 192-198
Abstract
Clinical guidelines widely recognize the importance of multidisciplinary meetings (MDM) in the optimal care of lung cancer patients. The published literature suggest that dedicated Lung Cancer MDM lead to increased treatment utilization rates and improved survival outcomes for patients with lung cancer. For radiation oncologists, Lung Cancer MDM have been proven to support evidence‐based practice and improve the utilization of radiotherapy. Lung Cancer MDM also allow for education and promotion of specialty radiotherapy services. The fast pace of modern medicine is also presenting new challenges for the multidisciplinary lung cancer team, and technological advances are likely to lead to new changes in the structure of traditional Lung Cancer MDM.Keywords
This publication has 27 references indexed in Scilit:
- Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancerAsia-Pacific Journal of Clinical Oncology, 2014
- Lung cancer in Victoria: are we making progress?Medical Journal of Australia, 2013
- What constitutes a multidisciplinary team meeting?Asia-Pacific Journal of Clinical Oncology, 2011
- Do multidisciplinary team meetings make a difference in the management of lung cancer?Cancer, 2011
- Do Multidisciplinary Meetings Follow Guideline-Based Care?Journal of Oncology Practice, 2010
- The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer☆European Journal of Cardio-Thoracic Surgery, 2010
- Why Do Some Lung Cancer Patients Receive No Anticancer Treatment?Journal of Thoracic Oncology, 2010
- Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for SurvivalJournal of Thoracic Oncology, 2007
- An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancerBritish Journal of Cancer, 2005
- Consensus: the follow-up of the treated patientLung Cancer, 2003